Clinical Trials in Minneapolis

Showing 3841-3860 of 14,456 trials

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

NCT04616196

This is a Phase 1b/2, open-label multicenter study evaluating NKTR-255 as a monotherapy and together with cetuximab in patients with head and neck squamous cell carcinoma (HNSCC) and colorectal carcinoma (CRC).

Head and Neck Squamous Cell CarcinomaColorectal Cancer

Nektar Therapeutics25 participantsStarted Oct 2020

San Diego, California, United States • San Francisco, California, United States • Minneapolis, Minnesota, United States +3 more locations

Active Not Recruiting< 1 mile

MRI of the TMJ in Patients With DJD

NCT07008690

This observational research is comparative in design, that is assessing the change in qMRI measures in degenerative changes of the TMJ in patients diagnosed with DJD. These patients will be imaged multiple times over the course of 18 months, using clinical 3T MRI scanners located at the Center for Magnetic Resonance Research (CMRR), and their findings will be compared to controls; individuals who are not diagnosed with DJD. No investigational agents or MRI contrast agents will be used.

Degenerative Joint DiseaseControl Subjects

University of Minnesota40 participantsStarted Apr 2025

Minneapolis, Minnesota, United States

RECRUITINGNA< 1 mile

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

NCT05219110

The objective of this study is to determine if early high volume intravenous fluid administration (hyperhydration) may be effective in mitigating or preventing complications of shiga toxin-producing E. coli (STEC) infection in children and adolescents when compared with traditional approaches (conservative fluid management).

Shiga Toxin-Producing Escherichia Coli (E. Coli) InfectionHemolytic-Uremic Syndrome

University of Calgary1,040 participantsStarted Sep 2022

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • La Jolla, California, United States +23 more locations

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

MRI of the TMJ in Patients With DJD

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

Find Trials by Condition in Minneapolis

Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial

Comparison of Lower vs Upper Extremity Injection Agitated Saline to Identify Patent Foramen Ovale With Echocardiography

Medical Access Program for Patritumab Deruxtecan

Electrical Nerve Block for Amputation Pain

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

TAC T-cells for the Treatment of HER2-positive Solid Tumors

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children

Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab

A Multi-Site Hybrid Type I Effectiveness-Implementation Randomized Trial of an Emergency Care Action Plan for Infants With Medical Complexity

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

Assessment of Early Pregnancy MAB Completion

Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections